Furthermore, it has been demonstrated that stromal fibroblast-derived MMP-9, involved in the cleavage of PD-L1 from melanoma cell surface, leads to anti-PD-1 therapy resistance in melanoma. This evidence concerns the gene MMP9 and melanoma.